KAMALA Harris urged people not to trust a COVID-19 vaccine touted by Donald Trump before the 2020 election.
Joe Biden's running mate Harris claimed the president will "muzzle, suppress, and sideline" health experts in an interview that airs on Sunday.
⚠️ Follow our US election 2020 live blog for the latest news & updates
Harris told CNN she doubted health experts would get the “last word” when it came to how effective the cure was.
“If past is prologue that they will not, they’ll be muzzled, they’ll be suppressed, they will be sidelined," she said.
"He’s looking at an election coming up in less than 60 days, and he’s grasping for whatever he can get to pretend that he’s been a leader on this issue when he’s not."
“I will say that I would not trust Donald Trump and it would have to be a credible source of information that talks about the efficacy and the reliability of whatever he's talking about
"I think that’s going to be an issue for all of us. I will say that I would not trust Donald Trump … I will not take his word for it."
The Trump administration is pushing for a vaccine to be produced before Election Day, CNN reported.
On Thursday, the station revealed that Trump pressured officials to speed up the vaccine development to appear as though the pandemic's end is in sight.
Last week, the CDC asked governors last week to accelerate building permit applications for vaccine distribution sites.
This is so these facilities would be running before November 3.
“Too much of the evidence points to the Trump administration pressuring the [Food and Drug Administration] to approve a vaccine by Election Day to boost the President’s re-election campaign,” Senate Minority Leader Charles Schumer said.
“All Americans want a safe and effective vaccine as soon as possible, but if these important life and death decisions appear political, it will only undermine Americans’ confidence in a vaccine and prolong the pandemic.”
But Dr Anthony Fauci has insisted the American public should trust health officials with a vaccine, insisting it "would not be approved for the American public unless it was indeed both safe and effective."
Meanwhile, a vaccine may be distributed in all 50 states as soon as late October or early November.
On Wednesday, the New York Times reported that the CDC had notified public health officials around the country to prepare to distribute a vaccine to health-care workers and high-risk groups.
A COVID-19 vaccine in late October or early November could mean it arrives before the day of the election.
The CDC provided planning scenarios for two coronavirus vaccines given that supplies "may be constrained" during the distribution.
CDC Director Dr. Robert Redfield asked states to waive requirements that could get in the way of distributing vaccines and set up distribution sites before Nov. 1.
Talks of a vaccine being available to certain groups including high-risk or health-care workers before clinical trials are done has been discussed by Dr. Anthony Fauci and FDA head, Dr. Stephen Hahn.
While the scenario documents propose distributing the vaccine as early as late October, it does not guarantee it will be available.
"The COVID-19 vaccine landscape is evolving and uncertain, and these scenarios may evolve as more information is available," one of the documents reads.
Saskia Popescu, an infection prevention epidemiologist told the Times that the timeline could be seen as a "push for a pre-election vaccine."
"This timeline of the initial deployment at the end of October is deeply worrisome for the politicization of public health and the potential safety ramifications," Popescu said.
If a vaccine is available by early November, the CDC cautions that it would be available in limited doses.
According to the scenarios, one of the vaccines, Vaccine A, seems to match Pfizer's, could have two million doses ready within the time frame and tens of millions of doses of each vaccine by the end of 2020.
In the documents released, the CDC said the vaccine would be free for patients but providers might not get reimbursements for administrative costs in emergency cases.
Several vaccines are currently in Phase 3 of their trials and are being developed by Moderna and Pfizer.
Over $10 billion has been committed to developing the vaccine however expenses for distributing the vaccines has not be specified.
Source: Read Full Article